The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

MORE: Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS The opposition ... from melanoma to HIV to Zika, according to clinical trials. The proposed bans ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...

The contract, signed in the final days of the Biden administration, is designed to help Moderna develop and test the safety and efficacy of vaccines to protect against five subtypes of influenza ...

The second vaccine, developed by Moderna in partnership with the National Institute of Allergy and Infectious Diseases, got the greenlight from the FDA days later. These steps are now overlapping ...

March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...